kifunensine has been researched along with miglustat in 3 studies
| Studies (kifunensine) | Trials (kifunensine) | Recent Studies (post-2010) (kifunensine) | Studies (miglustat) | Trials (miglustat) | Recent Studies (post-2010) (miglustat) |
|---|---|---|---|---|---|
| 94 | 0 | 47 | 383 | 28 | 185 |
| Protein | Taxonomy | kifunensine (IC50) | miglustat (IC50) |
|---|---|---|---|
| Sucrase-isomaltase | Mus musculus (house mouse) | 1.05 | |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | 5.55 | |
| Lysosomal acid glucosylceramidase | Homo sapiens (human) | 5 | |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | 0.1 | |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | 0.5 | |
| Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | 2.156 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 5 | |
| Glycogen debranching enzyme | Homo sapiens (human) | 10 | |
| Lysosomal alpha-glucosidase | Mus musculus (house mouse) | 9 | |
| Non-lysosomal glucosylceramidase | Mus musculus (house mouse) | 0.14 | |
| Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | 3.7 | |
| Non-lysosomal glucosylceramidase | Homo sapiens (human) | 0.2057 | |
| Putative alpha-glucosidase | Oryza sativa Japonica Group (Japanese rice) | 0.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcus, NY; Perlmutter, DH | 1 |
| Aricescu, AR; Chang, VT; Crispin, M; Davis, SJ; Dwek, RA; Harvey, DJ; Jones, EY; Rudd, PM; Yu, C | 1 |
| Burton, DR; Caulfield, M; Clayton, T; Cupo, A; Deller, MC; Doores, KJ; Feizi, T; Hoffenberg, S; Hua, Y; Julien, JP; Khayat, R; King, CR; Klasse, PJ; Kong, L; Le, KM; Lee, JH; Liu, Y; Marozsan, A; McBride, R; Moore, JP; Murin, CD; Paulson, JC; Sanders, RW; Stanfield, RL; Tien, H; Ward, AB; Wilson, IA | 1 |
3 other study(ies) available for kifunensine and miglustat
| Article | Year |
|---|---|
Glucosidase and mannosidase inhibitors mediate increased secretion of mutant alpha1 antitrypsin Z.
Topics: 1-Deoxynojirimycin; Alkaloids; alpha 1-Antitrypsin; Cell Line; Cell-Free System; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Glucosidases; Humans; Indolizines; Leupeptins; Mannosidases; Microsomes; Mutagenesis; Time Factors | 2000 |
Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway.
Topics: 1-Deoxynojirimycin; Alkaloids; alpha-Mannosidase; Animals; Cell Line; CHO Cells; Cricetinae; DNA, Complementary; Enzyme Inhibitors; Fucose; Glycoproteins; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swainsonine | 2006 |
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
Topics: 1-Deoxynojirimycin; Alkaloids; Amino Acid Motifs; Amino Acid Sequence; Antibodies, Neutralizing; Antigen-Antibody Reactions; Binding Sites, Antibody; Biopolymers; Carbohydrate Sequence; CD4 Antigens; Crystallography, X-Ray; env Gene Products, Human Immunodeficiency Virus; Epitopes; Glycosylation; HEK293 Cells; HIV Antibodies; HIV Envelope Protein gp120; Humans; Immunoglobulin Fab Fragments; Microscopy, Electron; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Polysaccharides; Protein Conformation; Protein Processing, Post-Translational; Structure-Activity Relationship | 2013 |